LIVE FROM THE DATABASETRANSACTIONS 723,446COMPANIES 6,570LATEST TRADE Oct 27UPDATED Oct 27, 10:30 PM
Reporting ownerCIK 0001618360

Sessa Capital (Master), L.P.

5 transactions in one company, from July 22, 2025 to September 29, 2025.

Transactions
51 company
Bought · P
$0open market
Sold · S
$0open market
Net
+$0net buying

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
SAB Biotherapeutics, Inc.SABS5——

All transactions

5 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
SAB Biotherapeutics, Inc.SABSSessa Capital (Master), L.P.DirDERIVJOINTSep 29MOption exercise17,400——211,100derivatives
SAB Biotherapeutics, Inc.SABSSessa Capital (Master), L.P.DirJOINTSep 29MOption exercise1,740,000$1.75$3.0M2,198,457
SAB Biotherapeutics, Inc.SABSSessa Capital (Master), L.P.DirDERIVJOINTJul 22AAward114,250——114,250derivatives
SAB Biotherapeutics, Inc.SABSSessa Capital (Master), L.P.DirDERIVJOINTJul 22AAward228,500——228,500derivatives
SAB Biotherapeutics, Inc.SABSSessa Capital (Master), L.P.DirDERIVJOINTJul 22AAward228,500——228,500derivatives